Inge A. M. van den Oever

Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system

Inge A. M. van den Oever, Naveed Sattar, Michael T. Nurmohamed · Annals of the Rheumatic Diseases · 2014 · 85 citations

Medicine, Immunology, Internal Medicine +16

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion

Inge A. M. van den Oever, Alper M. van Sijl, Michael T. Nurmohamed · Therapeutic Advances in Musculoskeletal Disease · 2013 · 48 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project

Inge A. M. van den Oever, Maaike Heslinga, E. N. Griep et al. · Lara D. Veeken · 2017 · 44 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis

Inge A. M. van den Oever, Milad Baniaamam, Suat Şimşek et al. · Rheumatology International · 2020 · 36 citations · Full text

Medicine, Endocrinology, Immunology +17

Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study

Alper M. van Sijl, Inge A. M. van den Oever, Matthew Peters et al. · Annals of the Rheumatic Diseases · 2011 · 32 citations

Medicine, Nephrology, Renal Pathophysiology +15